Detalhe da pesquisa
1.
Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors.
Clin Transplant
; 38(4): e15294, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38545881
2.
Optimizing cardiac status in the preliver transplant candidate.
Curr Opin Organ Transplant
; 29(1): 50-55, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991086
3.
Long-term follow-up of acute and chronic rejection in heart transplant recipients from hepatitis C viremic (NAT+) donors.
Am J Transplant
; 22(12): 2951-2960, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053676
4.
Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.
J Heart Lung Transplant
; 39(11): 1199-1207, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32739334
5.
Cardiac stem cells for myocardial regeneration: promising but not ready for prime time.
Curr Opin Biotechnol
; 47: 30-35, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591641
6.
Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3',5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Front Endocrinol (Lausanne)
; 8: 253, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067001
7.
Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome.
CASE (Phila)
; 4(4): 200-203, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426575
8.
COVID-19 pneumonia in a dual heart-kidney recipient.
J Heart Lung Transplant
; 39(6): 612-614, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32503728
9.
A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.
Nat Cell Biol
; 15(9): 1098-106, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23974038